is a biotechnology firm based in dundee scotland and short hills new jersey developing cancer drugs and treatments cyclacel was founded in 1996 by david lane merlin ventures and cancer research campaign technology with the university of dundee and the university of glasgow major shareholders include goldman sachs group tang capital management redmile group and ayer capital management the firm is developing mechanism targeted drugs to help in the fight of cancer and other serious illness such as diabetes and hiv cyclacel pharmaceuticals inc is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases sir david lane a recognized leader in the field of tumor suppressor biology who discovered the p53 protein founded the company in 1996 in 1999 cyclacel pharmaceuticals was joined by david glover a recognized leader in the mechanism of mitosis or cell division who discovered among other cell cycle targets the mitotic kinases polo and aurora enzymes that act in the mitosis phase of the cell cycle three product candidates are currently in clinical development sapacitabine cyc682 a cell cycle modulating nucleoside analogue is in phase 3 development for the treatment